• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
TIAN Xinxin,LI Zhongyuan,TIAN Jingzhen.Research progress on the active constituents and mechanisms of licorice in the treatment of infections caused by influenza virus, respiratory syncytial virus, and SARS-CoV-2[J].Journal Of Pharmaceutical Research,2025,44(6):605-613[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2015times   Download 751次 QR Code for this article
Scan with your phone!
甘草治疗流感病毒、呼吸道合胞病毒及新型冠状病毒感染的活性成分及作用机制研究进展
田圻新1,李忠原1,田景振1,2
Font:Larger+|Default|Smaller-
(1.山东中医药大学,山东 济南 250355;2.山东协和学院,山东 济南 250109)
摘要:
病毒是引发呼吸道感染的主要病原体之一,可导致肺组织损伤及炎症反应,甚至危及生命。在临床治疗和基础研究中,甘草展现出较好的抗呼吸道病毒作用。甘草活性成分复杂、作用机制多样,阐明甘草的活性成分及作用机制对于优化临床用药方案、合理开发甘草制剂以及发现新型抗病毒先导化合物具有重要意义。目前甘草抗呼吸道病毒活性成分及作用机制研究已经取得了显著进展,但仍有待更加深入、系统地挖掘。本文系统综述了甘草抗呼吸道病毒的活性成分及其作用机制研究现状,总结了相关研究方法,并对未来研究策略进行了深入探讨,旨在为甘草抗病毒活性成分的深入挖掘和作用机制研究提供新思路,同时为甘草资源的深度开发和临床应用提供理论依据。
关键词:  甘草  活性成分  作用机制  流感病毒  呼吸道合胞病毒  新型冠状病毒
DOI:10.13506/j.cnki.jpr.2025.06.015
基金项目:山东省重点研发计划(重大科技创新工程)项目(No.2020CXGC010505)
Publication Date:June 25, 2025
Research progress on the active constituents and mechanisms of licorice in the treatment of infections caused by influenza virus, respiratory syncytial virus, and SARS-CoV-2
TIAN Xinxin1,LI Zhongyuan1,TIAN Jingzhen1,2
(1.Shandong University of Traditional Chinese Medicine, Jinan 250000,China;2.Shandong Xiehe University, Jinan 250000,China)
Abstract:
Respiratory viruses are among the major pathogens responsible for respiratory tract infections, which can lead to pulmonary tissue damage, inflammatory responses, and even life-threatening conditions. In both clinical treatment and basic research, licorice has demonstrated promising antiviral activity against respiratory viruses. Given the complexity of its bioactive components and the diversity of its mechanisms of action, elucidating the active constituents and underlying mechanisms of licorice is of great significance for optimizing clinical applications, rational development of licorice-based preparations, and the discovery of novel antiviral lead compounds. In recent years, significant progress has been made in identifying the active constituents and mechanisms by which licorice combats respiratory viruses. However, further in-depth and systematic investigations are still needed. This review provides a comprehensive summary of current research on the active constituents and antiviral mechanisms of licorice against respiratory viruses, outlines the research methodologies employed, and discusses future research directions. The aim is to offer new insights for the further exploration of licorice’s antiviral constituents and mechanisms, and to provide a theoretical basis for the advanced utilization of licorice resources and their clinical application.
Key words:  Licorice  Active constituents  Mechanisms of action  IAV  RSV  SARS-CoV-2
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.